A Business Plan To Help The ‘Global South’ In Its Fight Against Neglected Diseases
- 1 November 2009
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 28 (6) , 1760-1773
- https://doi.org/10.1377/hlthaff.28.6.1760
Abstract
Although neglected tropical diseases (NTDs) threaten the health of those living in the developing world, innovation directed toward addressing NTDs is comparatively meager. Health biotechnology firms in rapidly growing economies in the global South are developing and selling vaccines, diagnostics, and therapeutics for these diseases to local markets. In this paper we identify a pipeline of sixty-two NTD products from seventy-eight “Southern” companies. We also propose creation of a Global Health Accelerator—a new nonprofit organization whose mission would be to support and help grow this Southern source of affordable innovation for NTDs.Keywords
This publication has 12 references indexed in Scilit:
- Small but tenacious: South Africa's health biotech sectorNature Biotechnology, 2009
- Chinese health biotech and the billion-patient marketNature Biotechnology, 2008
- Control of Neglected Tropical DiseasesNew England Journal of Medicine, 2007
- India's health biotech sector at a crossroadsNature Biotechnology, 2007
- Towards the elimination of onchocerciasisPathogens and Global Health, 2006
- Global framework on essential health R&DThe Lancet, 2006
- A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We NeedPLoS Medicine, 2005
- Health Innovation Networks to Help Developing Countries Address Neglected DiseasesScience, 2005
- Drug development for neglected diseases: a deficient market and a public-health policy failureThe Lancet, 2002
- Drugs for neglected diseases: a failure of the market and a public health failure?Tropical Medicine & International Health, 2001